What Ustekinumab Provides in Long-Term IBD Care - MD Magazine

Dr. Remo Panaccione speaks on promising long-term data of ustekinumab for Crohn's disease and ulcerative colitis, and how it could function as either a first-line treatment or alternative option for patients who were previously exposed biologic therapies.

Despite the bevy of biologics available for people struggling with Crohns disease and ulcerative colitis (UC), not all patients are able to respond to or tolerate a vast majority of approved therapie… [+2374 chars]

full article...